Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Investing Activities (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Cash from Investing Activities data on record, last reported at $2.9 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities changed N/A year-over-year to $2.9 million; the TTM value through Sep 2025 reached -$4.9 million, down 7644.44%, while the annual FY2024 figure was -$15.0 million, 613.27% down from the prior year.
  • Cash from Investing Activities reached $2.9 million in Q3 2025 per FBIO's latest filing, down from $6.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $53.4 million in Q4 2021 and bottomed at -$21.3 million in Q1 2022.
  • Average Cash from Investing Activities over 5 years is $662750.0, with a median of -$424500.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 3504.79% in 2021, then crashed 23709.52% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $53.4 million in 2021, then crashed by 100.73% to -$391000.0 in 2022, then skyrocketed by 83.89% to -$63000.0 in 2023, then plummeted by 23709.52% to -$15.0 million in 2024, then surged by 119.13% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $2.9 million in Q3 2025, $6.1 million in Q2 2025, and $1.2 million in Q1 2025.